Vivanza Biosciences Ltd — Important, 13-02-2026: Company Update

Vivanza Biosciences has announced its financial results for the quarter and nine months. For the quarter, consolidated total income from operations was ₹45.33 Cr, with a net profit of ₹0.20 Cr. Standalone figures showed total income of ₹45.01 Cr and a profit of ₹0.16 Cr. For the nine months, consolidated total income reached ₹109.65 Cr and net profit was ₹0.85 Cr. Standalone income for this period was ₹106.59 Cr with a profit of ₹0.64 Cr. These unaudited results, approved by the Board, provide investors an update on the company's operational performance.